Stock exchange and press releases of BBS will be published on these pages. Releases are published in Finnish and in English.
Contact information for the media: email@example.com from which you can also request additional media material.
BBS-Bioactive Bone Substitutes – Inside information: The final report of the second audit received from the Notified Body, CE marking process may continue and CE marking approval continues to be expected during 2023
Liquidation preference ends in Sweden
Older releases can be found from our news archive.